Fairmount Healthcare Fund II L.P. 4
4 · Viridian Therapeutics, Inc.\DE · Filed Oct 27, 2025
Insider Transaction Report
Form 4
Fairmount Funds Management LLC
Director10% Owner
Transactions
- Purchase
Common Stock
2025-10-23$22.00/sh+454,545$9,999,990→ 3,914,458 total(indirect: Fairmount Healthcare Fund II LP)
Footnotes (1)
- [F1]Fairmount Funds Management LLC ("Fairmount") and Fairmount Healthcare Fund II GP LLC ("Fairmount GP II") have voting power and investment power over the securities held by Fairmount Healthcare Fund II LP ("Fund II"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.